Format

Send to

Choose Destination
Nat Genet. 2010 Jun;42(6):492-4. doi: 10.1038/ng.585. Epub 2010 May 9.

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk.

Author information

1
Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK.

Abstract

Using data from a genome-wide association study of 907 individuals with childhood acute lymphoblastic leukemia (cases) and 2,398 controls and with validation in samples totaling 2,386 cases and 2,419 controls, we have shown that common variation at 9p21.3 (rs3731217, intron 1 of CDKN2A) influences acute lymphoblastic leukemia risk (odds ratio = 0.71, P = 3.01 x 10(-11)), irrespective of cell lineage.

PMID:
20453839
PMCID:
PMC3434228
DOI:
10.1038/ng.585
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center